QuickView for Phospholipase A2 domain (biogroup)

1. PBMCs of healthy beagles treated with concanavalin A (ConA) or 5-aminolevulinic acid (ALA)
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
4. Cancers from multiple organs of Prom1C-L mice
5. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens

There were no matches for Phospholipase A2 domain

1. Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
2. Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
3. Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranou…
4. Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
5. Personalized Medicine for Membranous Nephropathy